BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27577169)

  • 21. EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer.
    Bertucci F; Finetti P; Viens P; Birnbaum D
    Cancer Lett; 2014 Dec; 355(1):70-5. PubMed ID: 25218596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
    Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
    Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
    Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal instability: A common feature and a therapeutic target of cancer.
    Tanaka K; Hirota T
    Biochim Biophys Acta; 2016 Aug; 1866(1):64-75. PubMed ID: 27345585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX
    Curtit E; Mansi L; Maisonnette-Escot Y; Sautière JL; Pivot X
    Eur J Surg Oncol; 2017 May; 43(5):921-930. PubMed ID: 28087099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of chromosomal instability measures across mechanistic models.
    Lynch AR; Bradford S; Zhou AS; Oxendine K; Henderson L; Horner VL; Weaver BA; Burkard ME
    Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2309621121. PubMed ID: 38588415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Landscape of Chromosome Instability in Breast Cancers and Associations with the Tumor Mutation Burden: An Analysis of Data from TCGA.
    Voutsadakis IA
    Cancer Invest; 2021 Jan; 39(1):25-38. PubMed ID: 33306412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodes.
    Saghatchian M; Mook S; Pruneri G; Viale G; Glas AM; Guerin S; Cardoso F; Piccart M; Tursz T; Delaloge S; van't Veer L
    Breast; 2013 Oct; 22(5):682-90. PubMed ID: 23347730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.
    Carter SL; Eklund AC; Kohane IS; Harris LN; Szallasi Z
    Nat Genet; 2006 Sep; 38(9):1043-8. PubMed ID: 16921376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma.
    Okamoto T; Kohno M; Ito K; Takada K; Katsura M; Morodomi Y; Toyokawa G; Shoji F; Maehara Y
    Anticancer Res; 2017 Apr; 37(4):1729-1735. PubMed ID: 28373435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome instability and kinetochore dysfunction.
    Tomonaga T; Nomura F
    Histol Histopathol; 2007 Feb; 22(2):191-7. PubMed ID: 17149692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
    Park YH; Jung HH; Do IG; Cho EY; Sohn I; Jung SH; Kil WH; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH
    Int J Cancer; 2015 Apr; 136(8):1976-84. PubMed ID: 25537444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers.
    Sun X; Clermont PL; Jiao W; Helgason CD; Gout PW; Wang Y; Qu S
    Int J Cancer; 2016 Aug; 139(4):899-907. PubMed ID: 27062469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer.
    Le Du F; Gonzalez-Angulo AM; Park M; Liu DD; Hortobagyi GN; Ueno NT
    Clin Breast Cancer; 2015 Dec; 15(6):458-66. PubMed ID: 26233757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
    Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
    BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
    Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
    Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical relationship between chromosomal instability and survival outcome in cancer.
    Birkbak NJ; Eklund AC; Li Q; McClelland SE; Endesfelder D; Tan P; Tan IB; Richardson AL; Szallasi Z; Swanton C
    Cancer Res; 2011 May; 71(10):3447-52. PubMed ID: 21270108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy.
    Ding H; Gui X; Lin X; Chen R; Ma T; Sheng Y; Cai H; Fen Y
    Technol Cancer Res Treat; 2017 Oct; 16(5):645-653. PubMed ID: 27688262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.